2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine
C44H26N2O2 — CID 176817718
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine
2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine (PubChem CID 176817718) has the molecular formula C44H26N2O2 and a molecular weight of 614.70 g/mol. Its IUPAC name is 2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine.
Molecular Properties
| Compound Name | 2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine |
|---|---|
| PubChem CID | 176817718 |
| Molecular Formula | C44H26N2O2 |
| Molecular Weight | 614.70 g/mol |
| Exact Mass | 614.20 |
| IUPAC Name | 2-(5-phenylnaphtho[1,2-b][1]benzofuran-10-yl)-4-(4-phenylphenyl)-[1]benzofuro[3,2-d]pyrimidine |
| SMILES | c1ccc(-c2ccc(-c3nc(-c4cccc5c4oc4c6ccccc6c(-c6ccccc6)cc54)nc4c3oc3ccccc34)cc2)cc1 |
| InChI | InChI=1S/C44H26N2O2/c1-3-12-27(13-4-1)28-22-24-30(25-23-28)39-43-40(34-18-9-10-21-38(34)47-43)46-44(45-39)35-20-11-19-33-37-26-36(29-14-5-2-6-15-29)31-16-7-8-17-32(31)42(37)48-41(33)35/h1-26H |
| InChIKey | CIANBEORILRTBK-UHFFFAOYSA-N |
| XLogP | 12.10 |
| TPSA | 52.06 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 48 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 614.70 |
| LogP ≤ 5 | 12.10 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 176817718 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.